SABPA Newsletter, June 2018
In This Issue
Connect With Us
Subscribe to our WeChat 

SABPA Events

The 17th Annual San Diego Biopharma Conference 
When:   8:00am to 5:00pm, June 9, 2018
San Diego BioPharma Conference, the flagship event of SABPA, has been featuring some of the most respectful figures in the fields, from potential Nobel laureates and breakthrough innovators to multi-billion-dollar dealmakers. Many exciting stories from San Diego biopharma industry in the past year hit the global headlines and have ignited the passion that further fuels innovations. Come and meet some of the visionary leaders and network with your peers. This year’s topics include the pioneering exploration of gene therapies and proteome wide drug discovery, transformative academia research and its translation into life-saving therapeutics, the making of a multi-billion dollar deal, the challenges of navigating the drug R&D paths to ultimate success, and strategies to succeed in the ever-changing global market.  This is one of the biggest San Diego biotech events that you don’t want to miss. Please visit https://www.sabpa.org for more details.
QR Code

6th SABPA Bio-Partnering
SABPA Bio-Partnering is a great platform to explore opportunities in licensing, investment, fund raising and other collaboration deals.  It is designed for you to pre-arrange 1-on-1 face-to-face meetings with potential partners/investors/entrepreneurs by using the EBD online tool Partnering360*.  Participants can upload their profile to the platform, and send invitations to other participants.   Once the invitations are accepted, the 30 min private meetings will be arranged automatically.   Participants will have access to pre-scheduled 1-on-1 meetings in designated meeting areas during the conference, as well as access to Partnering360 database all year round.   Bio-Partnering will be hosted at the same time and venue with SABPA Bio-Pharma Conference (06/09/2018).  Please check the link below for more details.
Who shall attend?
  • Entrepreneurs and executives from local biotech and pharmaceutical companies
  • Chinese pharmaceutical companies who are looking for collaboration opportunities
  • Investors from local firms and across Pacific
  • Biotech or pharmaceutical service providers
How to Participate?
Register for SABPA Bio-Partnering event and SABPA Pacific Forum at the link below:
      ($100, online only, includes: SABPA Bio-Pharma Conference, dinner)
Receive a private Partnering360 log-in link sent by Whova after your registration
Access Partnering360 to setup your profile and schedule meetings. Step-by-step instruction is available here:     https://www.sabpa.org/1on1instruction2017/
Please act early to allow time for meeting arrangement (> 2 weeks prior to the event date)
Need Help? Please email:


* Partnering360 is a 3rd party (EBD Group) online software used to schedule meetings for SABPA Bio-Partnering.

Community Events

BioDuro Symposium: 

Innovative Approaches to Drug Discovery and Development:
How can we accelerate successful drug discovery and development?
The success of clinical candidate development depends on several factors, important among them are generation of novel, therapeutically-relevant chemical structures, early and rapid assessment of possible efficacy of candidate structures in pre-clinical therapeutic models and rapid elimination of candidates that will ultimately prove unsuccessful. Innovative processes and techniques that facilitate optimal candidate selection is a crucial step in accelerating drug discovery and development timelines.
Join us on Thursday, June 14, 2018 at Farmer & the Seahorse 10996 Torreyana Rd, San Diego, CA 92121 for an afternoon of lunch, insightful presentations and discussion, followed by a networking and happy hour reception.
11:30 AM- 12:30 PM
Registration & Lunch, Opening Remarks
12:30 PM- 4:50 PM
4:50 PM- 5:00 PM
Closing Remarks
5:00 PM- 6:00 PM
Networking Reception and Happy Hour
Why Bother? Impact of Downstream Development and Market Considerations on Discovery Projects
Vince Wacher, Ph. D. | Product Development and Planning
The ReFRAME Drug Repositioning Library: Building and Applications to Neglected Diseases
Arnab Chatterjee, Ph. D. | VP Medicinal Chemistry | Calibr
Paving the Road to the Clinic: Advancing Oncology Drug Development with Translational In Vitro and In Vivo Models
Tommy Broudy, Ph. D. | CEO | Molecular Response
BioDuro Solution Engine: Enabled Formulations Bridging Discovery and Development
Blair West, Ph. D. | CSO, Global CMC Solutions | BioDuro
Development of Poorly Soluble Compounds: Discovery to FIH and Later Clinical Development Phases
Hamid Rezai, Ph. D. | Senior Director of Pharmaceutics | Plexxikon Inc.
Reactive Melt Extrusion to Improve Properties of Amorphous Solid Dispersions
Feng Zhang, Ph. D. | Assistant Professor of Pharmaceutics | University of Texas at Austin

Biocom Educational Session
Date: June 20th, 8-10 AM, 2018
Venue: Biocom McGraw Boardroom- 10996 Torreyana Rd. Suite 200, San Diego, CA
Do you wish to keep abreast of the new developments in cutting-edge screening technologies? Are you trying to rise to the challenge of working with “undruggable” targets? If so, come join us at the next Biocom CRO Educational Session on June 20th. This program will showcase some of the most advanced technologies to help address the challenges that scientists are facing today when low hanging fruits in drug discovery are harder to find. Three featured speakers from Viva Biotech, Takeda Pharmaceuticals and Asellus Therapeutics will be sharing with the audience their know-how and insights from different perspectives. Case studies using different approaches will also be demonstrated. We look forward to a great discussion with all of you who are passionate about technology innovation and drug discovery.
8:00AM     Introduction – Yinghong Gao, Executive Director, Business Development, Viva biotech
8:15AM     ASMS Screening as an Enabling Platform for Early Lead Discovery – Dr. Shawn Cheng, CTO of Viva Biotech
8:45AM     Takeda’s Tool Kit of Biophysical Methods – Dr. Elisa Barile, Senior Scientist, Takeda Pharmaceuticals
9:15AM     Humanized 3D Modeling for Oncology Drug Discovery – Dr. Brett Hall, CEO of Asellus Therapeutics
9:45AM     Q&A
Shawn Cheng, PhD,
CTO, Viva Biotech
Elisa Barile, PhD, 
Senior Scientist, Takeda Pharmaceuticals
Brett Hall, PhD,
CEO, Asellus Therapeutics

USP WCDG & AOAC-SCS Joint Two-Day Regulatory & Compliance Conference, “Critical Regulatory and Compliance Issues with the US FDA in the 21st Century”
When:  Wednesday, June 27, and Thursday, June 28, 2018

Where: Chapman University, School of Pharmacy, Harry and Diane Rinker Health Science Campus. 9401 Jeronimo Rd., Irvine, CA 92618.Conference Room 181

Registration: http://www.aoac-scs.org/2018-spring-conf.html    (Breakfast and lunch are included)
Early prepaid registration (received by Friday, 06/15/18) is $ 10.00 less except for students & FDA Employees. REGISTRATION FOR FIRST TWO STUDENTS IS FREE! (Current Students interested in attending this conference must email their proof in the form of a Student ID or an Official Letter along with their Registration Forms) If you have questions regarding conference registration, please contact: Gina Zhang, E-mail:gina.zhang@medtronic.com
USP Western Compendial Discussion Group (WCDG) – AOAC Southern California Section (SCS) kindly offer SABPA members the same registration rates as the AOAC SCS member (please make a note that you are a SABPA member when registering and/or checking in)
Event Summary:
This conference will be focused on Current Critical Issues on Pharmaceuticals, Biologics and Medical Devices with speakers from the US FDA, academic institutes and industry.
DAY 1 – Wednesday, June 27, 2018
7:30 A.M.        Registration & Continental Breakfast
8:40 A.M.        Welcome Remarks by
Sumit Sen, Ph.D., US FDA, PSL, Irvine, CA, President, AOAC SCS & USP WCDG, & Master of Ceremony
Ronald Jordan, Ph.D. Dean, Chapman University School of Pharmacy, Irvine, CA
9:10 A.M.        KEYNOTE SPEAKER: Mahesh Ramanadham, Ph.D.
TOPIC: The Integration of Quality Assessments and Inspection
10:00 A.M.      Aryo Nikopour
Senior Vice President, Scientific & Technical Services,
Nitto Avecia Pharma Services, Irvine, CA
TOPIC: Systematic Approach to Extractables & Leachables: A Review of
Guidance from the Industry
10:50 A.M.      Refreshment Break
11:10 A.M.      Timothy Moseley, Ph.D.
Chief Scientific Officer, Paisley Laboratories, LLC, San Diego, CA
TOPIC: Stem Cell Therapy and Management of Regulatory Requirements
12:00 P.M.      Lunch Break and Networking
1:15 P.M.        Sponsor Presentations
2:00 P.M.        Panel Discussion Session
4:30 P.M.        Adjourn
DAY 2 – Thursday, June 28, 2018
7:30 A.M.        Registration & Continental Breakfast
9:00 A.M.        KEYNOTE SPEAKER: Susan Rosencrance, Ph.D.
Director, FDA/OMPT/CDER/OPQ/OLDP, Silver Spring, MD
TOPIC: The Modernization of Quality Assessments for Generic Drugs
9:50 A.M.        SPECIAL INVITATION: Lokesh Bhattacharyya, Ph.D.,
TOPIC: Replacing Analytical Methods for Biologics-Pre-Approval and Post-Approval
10:40 A.M       Refreshment Break
11:10 A.M.      Danita Scott Broyles
Merck Compendial Affairs – Senior Compendial Affairs Specialist, West
Point, PA
TOPIC: USP’s General Chapter <661> Plastics Packaging used in Pharma & Medical Device Industries & its Challenges
12:00 P.M.      Lunch Break and Networking
1:15 P.M.        Sponsor Presentations
2:00 P.M.        Panel Discussion Session
4:30 P.M.        Adjourn
To register or to learn more about this exciting event, please visit:

21 Annual San Diego MedChem Symposium

Organized by

Dr. Ben Pratt, Dr. Mark Tichenor, Dr. David Wallace – San Diego Section of the American Chemical Society
Dr. Emmanuel Theodorakis – UCSD Department of Chemistry and Biochemistry
8:30 AM                   Registration and Continental Breakfast
9:00                          Opening Remarks: Emmanuel Theodorakis
9:05                           Dr. Simon Bailey, Intercept Pharmaceuticals
                                    “Incorporating natural product-like features in medicinal chemistry”
9:50                          Dr. Thomas Hermann,University of California San Diego
                                   “Small Targeting of Viral Noncoding RNA”
10:35                         Coffee Break
10:50                        Dr. Arnab Chatterjee, California Institute for Biomedical Research (Calibr)
                                    “Intra-muscular injections for malaria chemoprotection”
11:35                        Dr. Holly Reichard, Takeda Pharmaceuticals
“Discovery of TAK-041: Potent and selective GPR139 agonist for treatment of negative symptoms associated with schizophrenia”
12:20 PM                  Lunch
1:20                          Dr. Jin-Quan Yu, The Scripps Research Institute
                                    “Enantioselective and Remote C-H Activation Reactions”
2:05                          Dr. Cheryl Grice, Abide Therapeutics
                                   “Discovery of ABX-1431: A Potent and Selective MGLL Inhibitor for Clinical Development”
2:50                            Symposium Conclusion
To register please visit:
follow the link to the registration page.
Register online by Friday, July 13, and food will be provided.

Our Platinum Corporate Sponsors

Our Gold Corporate Sponsors
Sino-American Biotechnology and Pharmaceutical Professionals Association (SABPA) is an 501(c)(3) nonprofit organization founded in early 2002 by professionals and scholars from the Chinese community in San Diego. In 2005, we expanded to Orange County and Los Angeles. We invite all scholars, professionals and entrepreneurs of any origin who are working in, engaged in, or interested in the biotech and pharmaceutical industry in Southern California to join us as a member of SABPA.
Our Mission
  • Provide a forum to facilitate professional contact and communication among local Chinese American professionals in academia, biotech and pharmaceutical industries;
  • Foster professional growth, career improvement and personal development of our members;
  • Provide opportunities to educate local communities about the values of biomedical research and the benefits of biotech and pharmaceutical innovations;
  • Stimulate and facilitate the development of relationships between the U.S. and China in biotech and pharmaceutical communities.
  • To fulfill our mission, we will sponsor professional seminars, meetings, and symposia; share employment opportunity information in local biotech and pharmaceutical industry; sponsor social events; and disseminate information about local biotech and pharmaceutical companies.